Complications of Radiofrequency Ablation for Supraventricular Tachycardia in the Wolff-Parkinson-White Syndrome Associated With Noncompaction Cardiomyopathy

2018 ◽  
Vol 121 (11) ◽  
pp. 1442-1444
Author(s):  
William C. Roberts ◽  
Paul A. Grayburn ◽  
Shelley A. Hall
2002 ◽  
Vol 12 (3) ◽  
pp. 248-252 ◽  
Author(s):  
Anne M. Dubin ◽  
Kathryn K. Collins ◽  
Nancy Chiesa ◽  
Debra Hanisch ◽  
George F. Van Hare

In adults with Wolff-Parkinson-White syndrome, the likelihood of sudden death can be estimated based upon the presence or absence of symptoms. Comparable data in children do not exist. To date, therefore, invasive risk stratification has been used to guide management regarding radiofrequency ablation in symptomatic children. As the safety of electrophysiology study and radiofrequency ablation in children has improved, asymptomatic patients have been referred more commonly for invasive risk stratification. We sought to compare the findings from electrophysiologic studies in symptomatic children with Wolff-Parkinson-White syndrome to the findings in asymptomatic children with Wolff-Parkinson-White pattern on their electrocardiogram. Thus, we compared the findings from electrophysiologic studies carried out in patients seen at Stanford University and University of California, San Francisco, from April 1999 to February 2001 with a preexcitation pattern on their electrocardiogram. The patients were divided into three groups: 23 asymptomatic patients studied for risk stratification, 19 patients who presented with syncope, and 77 patients presenting with documented supraventricular tachycardia. Data were collected for commonly accepted invasive criterions for stratification of risk: an effective refractory period of the accessory pathway less than 270 ms, multiple pathways, septal location of pathway, and inducibility of supraventricular tachycardia. Groups were compared by chisquare. No differences were found between the groups for any of the variables. These data suggest that risk factors for sudden death, developed in studies of adult patients, are not clearly applicable to children. Further studies are needed better to define the indications for study and ablation in children.


2017 ◽  
Vol 19 (1-2) ◽  
pp. 56
Author(s):  
T.S. Kustiman ◽  
J. Abdulkadir ◽  
A. Alisjahbana

A case of paroxysmal supraventricular tachycardia with Wolff-Parkinson-White syndrome in an Indonesian neonate born in the Departement of Obstetrics, Dr. Hasan Sadikin General Hospital, Bandung, is reported. Tachycardia in the neonate was first noted at the age of 6 days, but the heart rate gradually decreased in 8 hours after oxygen was administered. Electrocardiographic examination revealed a Wolff-Parkinson-White syndrome. A second attack of tachycardia occurred at the age of 2 months and the infant was immediately hospitalized and treated with lanoxin. Serial electrocardiographic examination still revealed the same syndrome. The management and prognosis of supraventricular tachycardia in the neonate is also discussed.


2019 ◽  
Vol 2019 ◽  
pp. 1-5
Author(s):  
Mohammed Abdullahi Talle ◽  
Faruk Buba ◽  
Aimé Bonny ◽  
Musa Mohammed Baba

Syncope is a common manifestation of both hypertrophic cardiomyopathy (HCM) and Wolff-Parkinson-White (WPW) syndrome. The most common arrhythmia in HCM is ventricular tachycardia (VT) and atrial fibrillation (AF). While preexcitation provides the substrate for reentry and supraventricular tachycardia (SVT), AF is more common in patients with preexcitation than the general population. Concurrence of HCM and WPW has been reported in many cases, but whether the prognosis or severity of arrhythmia is different compared to the individual disorders remains unsettled. We report a case of HCM and Wolff-Parkinson-White (WPW) syndrome in a 28-year-old male Nigerian soldier presenting with recurrent syncope and lichen planus.


Sign in / Sign up

Export Citation Format

Share Document